Founded in 2015 as a Carnegie Mellon University spin-off, Pittsburgh-based Humotech develops wearable robotics and mobility technology for prosthetic research, clinical evaluation, and human-movement innovation. Its Caplex® platform lets researchers and clinicians emulate different mechanical behaviors with modular systems, while the company’s FDA-registered Clinical Caplex® System supports data-driven prosthetic-foot trials for people with limb loss. Founder Josh Caputo’s original question—whether robotics could create a better prosthetic foot—still shapes Humotech’s work across the laboratory and clinic.
FDA Registered
registration
HIPAA Compliant
compliance_program